世界のコンパニオンアニマル医療市場：製品別（ワクチン、寄生虫駆除剤、抗炎症薬、医療用食品添加物、その他の医薬品）、診断技術別、動物別（犬、猫、馬）、地域別 - 動向および予測
Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)
|発行||Mordor Intelligence LLP||商品コード||319394|
|世界のコンパニオンアニマル医療市場：製品別（ワクチン、寄生虫駆除剤、抗炎症薬、医療用食品添加物、その他の医薬品）、診断技術別、動物別（犬、猫、馬）、地域別 - 動向および予測 Companion Animal Health Market By Products (Vaccines, Paraciticides, Anti-Infectives, Medicinal Feed Additives, And Other Pharmaceuticals), By Diagnostic Technologies, By Animals Type (Dogs, Cats And Horses), By Geography-Trends And Forecast (2016-2021)|
|出版日: 2016年01月01日||ページ情報: 英文||
The global market for companion animal healthcare is valued at USD 9.8 billion in 2015 and it is projected to reach USD 14.43 billion by 2020 at a CAGR of 7.86% during the forecast period 2015-2020.
Veterinary healthcare deals with food safety; prevention, diagnosis and treatment of diseases, disorders or any injuries in animals and consistently monitoring the health of animals. In United States alone, Americans spent more than USD 53 billion on food, pet supplies, over-the-counter and prescription medications, veterinary care, live animal purchases, and other pet-related services.
The end-user market is segmented into veterinary hospitals, clinics and reference laboratories. Veterinary Hospitals and clinics are the major sub segments contributing to the economic growth of this market. Pet owners/lovers utilize the animal health services provided by physicians or care providers.
Rising incidence of diseases (food-borne and zoonotic) in animals which consequently transfer to human beings and awareness for animal health, are the major driving factors for the market. Another factor that drives the market is continuous innovations and technological advances in development of animal health drugs. On other hand, Scarcity of arable land and water, increased competition for cultivated land and Cost effective production are constraining the growth of this market.
The companion animal health market is segmented based on Product type, Animal Diagnostics and Animal Genetics. Animal products segment includes Vaccines, Parasiticides, Anti-infectives, Feed additives and Pharmaceuticals. Feed additives is further segmented into Nutritional Feed Additives and Medicinal Feed Additives. Animal diagnostics segment includes Enzyme Linked Immuno Sorbent Assay (ELISA), Rapid Immuno Migration (RIM) and Agar Gel Immuno Diffusion (AGID). The genetics segment includes sub-segments like HD 50K for Angus, CLARIFIDE® for Dairy, Sheep 50K and CLARIFIDE® for Nelore.
Based on geography, the market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, and Brazil will be the major contributors in the market.
Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market